The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
about
Interventions for fatigue management after traumatic brain injuryFatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain StimulationA practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosisThe thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic reviewThe Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigueFatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathwaysTherapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy.Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis.Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosisRandomized controlled trial of a teleconference fatigue management plus physical activity intervention in adults with multiple sclerosis: rationale and research protocol.The representation of inflammatory signals in the brain - a model for subjective fatigue in multiple sclerosis.Axonal damage in multiple sclerosis.Treatment of fatigue in multiple sclerosis patients: a neurocognitive approach.Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study.Perception of Pain Self-efficacy and Fatigue in Greek Patients with Multiple Sclerosis: A Study Protocol.Origin of fatigue in multiple sclerosis: review of the literature.Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis.Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.Fatigue versus activity-dependent fatigability in patients with central or peripheral motor impairments.Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.Depression in multiple sclerosis: review and theoretical proposal.Effects of Six Months Training on Physical Capacity and Metaboreflex Activity in Patients with Multiple Sclerosis.Multiple sclerosis-associated fatigue.The role of mitochondria in axonal degeneration and tissue repair in MS.Pathophysiology, assessment and management of multiple sclerosis fatigue: an update.Evaluation of the Persian version of modified fatigue impact scale in Iranian patients with multiple sclerosis.Mental fatigue alters the pattern and increases the volume of cerebral activation required for a motor task in multiple sclerosis patients with fatigue.Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study.Cognitive fatigue: an impaired cortical inhibitory replenishment.Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis.Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.Cortico-muscular coherence as an index of fatigue in multiple sclerosis.Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors.Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study.The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue.
P2860
Q24245645-BD9D07EB-4971-4454-B933-34841421BD1BQ26773166-2E2DA243-B962-4EF2-BC1F-7EBDD5605705Q26776231-9F15E8CC-7D3C-410C-875D-A163F23883A8Q26851476-B08CFFE0-E396-4CEA-9063-EC2B82DD96B8Q27007478-93EDD401-37ED-47B7-9467-DCD4DAEADF16Q28073849-2A054257-8017-46B6-82BC-B4147CD3B1B4Q28299922-904C1F27-B22C-48D1-8E2D-94050D7CAD9AQ30869048-C940AB10-0B9B-4F27-BB70-100F7CC1F2C1Q31001850-31B1CCCE-8FF3-4057-AEED-ABD514DF9B34Q31027957-2C45913C-0D44-42C8-9FDE-F1CFC75FA4B3Q33158552-DC6E809B-E769-465E-9DA8-B2F5F660D2B8Q34021881-AEDCE36F-A1E3-44BA-AB57-155D09E41E98Q34281084-CFC32A4C-A121-45C2-8219-1AD7B7EB9935Q34448537-63F5FF57-9426-4789-807B-0196E5C4E35FQ34677503-D4AD1330-D9D3-47D3-AB68-7BEE7D7EFEA4Q35126104-8288B33E-FE8B-4353-80AA-4BFA91C826F8Q35390868-ED87BA73-E7D7-410A-A6BC-892EBCFB525DQ35864382-A0CAA4E5-84F5-4EE7-8E91-01802C1D7C8AQ36026962-3F1EBCB3-70C6-474B-AE06-EDC4A61BD6D4Q36622545-81E7681C-4433-442E-81B8-E97A975AF150Q36780439-EF26817B-3180-41D3-A5CD-8C4B67DD8B0AQ36889694-7D3CDCDE-1B2D-40DD-AA5C-2214153E7DE1Q37001036-2E0678E5-FD4F-4D82-83EA-A3B042CA019BQ37088804-F550A1C0-1914-44D3-AA0E-D01128B708DAQ37142971-944985DF-D767-44B7-98FD-E4005BF0A485Q37258747-3AC353E2-75E2-418A-BC71-BBAD1A8F0839Q37412225-9CB17D4D-1DCE-4C99-ACDC-3E7621D51D4FQ37785555-2184B259-16D4-4A6D-AA64-CEF2A3546859Q38020826-77F1DBB2-9924-4020-8204-C2E7DBCB555BQ38978087-EE3D6D14-06AE-40AC-ADF6-B47AF49E0086Q42905689-6DCF3F3C-65E3-4A78-AEDB-0C82C98B1EAEQ44674662-DA040174-AFDE-4DD5-9ED9-209B894B7E2BQ46548040-400DA62D-46DF-4934-94C2-467CBC3AE406Q47704039-AF036827-D057-4FAF-827B-6740B6E7AF86Q48106940-01C76242-A6EE-4BE7-A9D3-4B1C13C7DDF2Q48424430-77735798-08B5-46FD-9BFC-B719A8B57003Q48452114-AEDCA71B-FFB4-4CD8-B2ED-3FA5EDF4AC73Q48470311-96B93FC2-01FF-475C-82B0-3814C4B06F37Q48620156-49CB0D22-F5A9-4E08-9CE7-46F546443B5AQ48946667-C9FD8DDE-722E-4DC8-8D8C-EF67B7AB16E5
P2860
The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
@en
The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
@nl
type
label
The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
@en
The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
@nl
prefLabel
The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
@en
The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
@nl
P2093
P1433
P1476
The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
@en
P2093
Antonio Carlos Santos
Douglas L Arnold
Maria Carmela Tartaglia
Simon J Francis
Sridar Narayanan
Yves Lapierre
P304
P356
10.1001/ARCHNEUR.61.2.201
P577
2004-02-01T00:00:00Z